Expression of mTOR mRNA and Tfr1 mRNA in mucoepidermoid carcinoma of parotid gland and their relationship with prognosis

doi:10.19439/j.sjos.2019.05.010

Abstract

Abstract: PURPOSE: To investigate the expression of rapamycin target protein (mTOR) mRNA and transferrin receptor 1(Tfr1) mRNA in mucoepidermoid carcinoma of parotid gland and its relationship with prognosis. METHODS: From June 2013 to July 2015 in Tangshan Workers' Hospital, 35 patients with mucoepidermoid carcinoma of parotid gland were selected. The relative expression of mTOR and Tfr1 mRNA in mucoepidermoid carcinoma of parotid gland was detected. The relationship between mTOR mRNA, Tfr1 mRNA and the clinicopathology and prognosis of mucoepidermoid carcinoma of parotid gland was analyzed using SPSS19.0 software package. RESULTS: The relative expression levels of mTOR mRNA and Tfr1 mRNA in mucoepidermoid carcinoma of parotid gland were significantly higher than those in adjacent tissues(P<0.05). The relative expression of mTOR mRNA and Tfr1 mRNA was correlated with invasion depth, tumor grade, TNM stage and cervical lymphatic metastasis(P<0.05). The relative expressions of mTOR and Tfr1 in patients with good prognosis were significantly lower than those in patients with poor prognosis (P<0.05). The AUC of mTOR mRNA was 0.815, higher than that of Tfr1 mRNA(0.813). The AUC of mTOR mRNA combined with Tfr1 mRNA was 0.922, higher than that of mTOR mRNA and Tfr1 mRNA alone. Cox univariate and multivariate analysis showed that differentiation, TNM stage, mTOR mRNA and Tfr1 mRNA were closely related to poor prognosis of mucoepidermoid carcinoma of parotid gland. CONCLUSIONS: The relative expression of mTOR mRNA and Tfr1 mRNA in patients with mucoepidermoid carcinoma of parotid gland was significantly increased, which can be used to evaluate the prognosis of patients.

Key words: Rapamycin target protein mRNA, Transferrin receptor 1 mRNA, Mucoepidermoid carcinoma of parotid gland, Prognosis, Relative expression

CLC Number:

R739.8

CHANG Pan-hui, AKBEL Turgesjon, LI Wei-wei. Expression of mTOR mRNA and Tfr1 mRNA in mucoepidermoid carcinoma of parotid gland and their relationship with prognosis[J]. Shanghai Journal of Stomatology, 2019, 28(5): 499-503.

References

[1] 童国勇, 余周庆, 戈春城. 彩超引导下的粗针穿刺活检术在腮腺肿瘤诊断中的应用[J]. 口腔医学研究, 2017, 33(3):108-110.
[2] Rajasekaran K, Stubbs V, Chen J, et al.Mucoepidermoid carcinoma of the parotid gland: a national cancer database study[J]. Am J Otolaryngol, 2018, 39(3):321-326.
[3] Kissing S, Rudnik S, Damme M, et al.Disruption of the vacuolar-type H+-ATPase complex in liver causes MTORC1-independent accumulation of autophagic vacuoles and lysosomes[J]. Autophagy, 2017, 13(4):670-685.
[4] Li H, Choesang T, Bao W, et al.Decreasing TfR1 expression reverses anemia and hepcidin suppression in 2-thalassemic mice[J]. Blood, 2017, 129(11):1514-1526.
[5] Peng L, Song L, Liu C, et al.piR-55490, inhibits the growth of lung carcinoma by suppressing mTOR signaling[J]. Tumor Biol, 2016, 37(2):2749-2756.
[6] Magro G, Cataldo I, Amico P, et al.Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target[J]. Thyroid, 2011, 21(3):267-277.
[7] Vasudevan G, Bishnu A, Bmk S, et al. Mucoepidermoid carcinoma of salivary gland: limitations and pitfalls on FNA[J]. J Clin Diagn Res, 2017, 11(5):ER04-ER06.
[8] Sobral APV, Loducca SVL, Kowalski LP, et al.Immunohistochemical distinction of high-grade mucoepidermoid carcinoma and epidermoid carcinoma of the parotid region[J]. Oral Oncol, 2002, 38(5):437-440.
[9] Matthew EM, Hart LS, Astrinidis A, et al.The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth, and chemosensitivity under hypoxic conditions[J]. Cell Cycle, 2009, 8(24):4168-4175.
[10] Kawabata H, Tong X, Kawanami T, et al.Analyses for binding of the transferrin family of proteins to the transferrin receptor 2[J]. Br J Haematol, 2015, 127(4):464-473.
[11] Smilevska T, Stamatopoulos K, Samara M, et al.Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia[J]. Leuk Res, 2006, 30(2):183-189.
[12] Nakamura Y, Nakamichi N, Takarada T, et al.Transferrin receptor-1 suppresses neurite outgrowth in neuroblastoma Neuro2A cells[J]. Neurochem Int, 2012, 60(5):448-457.
[13] 陈柯君, 程辉, 王健民, 等. mTOR通路下游核心分子的mRNA表达水平与初发AML患者临床特征的关系[J]. 中国临床医学, 2016, 23(1):17-21.
[14] Hicks MJ, El-Naggar AK, Flaitz CM, et al.Histocytologic grading of mucoepidermoid carcinoma of major salivary glands in prognosis and survival: a clinicopathologic and flow cytometric investigation[J]. Head Neck, 2010, 17(2):89-95.
[15] Shi L, Chen XM, Wang L, et al.Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome[J]. Cancer, 2007, 109(8):1523-1531.